Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-05-03Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use DisorderUnknown journal · 2026-05-01C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine · 2026-04-301080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEP · 2026-04-30Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use DisorderAmerican Journal of Neuroradiology · 2026-04-23Prevalence and Correlates of Past-Year Psilocybin Use in the United StatesAmerican Journal of Psychiatry · 2026-04-21Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory DepressionClinicalTrials.gov · 2026-03-2626-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORTJournal of the American College of Cardiology · 2026-03-26Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescenceNeuropsychopharmacology · 2026-02-17Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use DisorderClinicalTrials.gov · 2026-02-11Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-01Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-18Sudden Loss of Consciousness Following Psilocybin IngestionAmerican Journal of Psychiatry · 2025-11-30Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Psilocybin and chronic neuropathic pain: a systematic review.Unknown journal · 2025-11-04S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialPLoS Medicine · 2025-09-18Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-03Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-08-31US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022Journal of the American College of Emergency Physicians Open · 2025-08-29Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Psilocybin’s acute and persistent brain effects: a precision imaging drug trialScientific Data · 2025-06-04Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushroomsAmerican Journal of Ophthalmology Case Reports · 2025-06-01The pharmacological treatment of anxiety in people with eating disorders: A systematic review.Unknown journal · 2025-05-13187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-08Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-03Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin TreatmentAmerican Journal of Psychiatry · 2025-02-28Effects of Psilocybin on Mouse Brain MicrostructureAmerican Journal of Neuroradiology · 2025-01-28Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label TrialAmerican Journal of Psychiatry · 2024-12-31Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialAmerican Journal of Psychiatry · 2024-12-31Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13Psilocybin desynchronizes the human brainNature · 2024-07-16Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-06-30Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-AACS Chemical Neuroscience · 2024-06-24The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderPLoS ONE · 2024-03-13Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinAmerican Journal of Therapeutics · 2024-02-29Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot studyScientific Reports · 2024-02-06Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative studyScientific Reports · 2024-02-04Flies on ’Shrooms: Studying the Psychotherapeutic Potential of Psilocybin using DrosophilaAmerican Entomologist · 2023-11-30Novel treatments for anorexia nervosa: Insights from neuroplasticity research.Unknown journal · 2023-10-116.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the ResearchJournal of the American Academy of Child & Adolescent Psychiatry · 2023-09-30Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31Must Psilocybin Always “Assist Psychotherapy”?American Journal of Psychiatry · 2023-07-11A case-study evaluation of the “Copenhagen Music Program” for psilocybin-assisted therapyFrontiers in Psychology · 2023-06-15HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerJournal of Pain and Symptom Management · 2023-06-09Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memoriesPsychopharmacology · 2023-06-01A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric historyPsychiatry Research Case Reports · 2023-04-25Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug AvailabilityAmerican Journal of Psychiatry · 2022-11-30A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive EmergencyJournal of the American Society of Nephrology · 2022-10-31Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-3119.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical ConsiderationsJournal of the American Academy of Child & Adolescent Psychiatry · 2022-09-30Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.ACS Chemical Neuroscience · 2022-08-23Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational Psychiatry · 2022-08-01Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.NeuroImage · 2022-07-01Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-06-08Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain · 2022-03-31Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of Psychopharmacology · 2022-01-31Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in Neuroergonomics · 2022-01-19P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-11-30Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-196.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDERJournal of the American Academy of Child & Adolescent Psychiatry · 2021-09-30Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-18Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03Psilocybin Therapy May Work as Well as Common AntidepressantScientific American · 2021-06-30Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.The American Journal of Drug and Alcohol Abuse · 2021-06-04Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of Psychopharmacology · 2021-02-19Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Psilocybin Treatment for Mental Health Gets Legal FrameworkScientific American · 2021-01-31Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of Psychopharmacology · 2021-01-08Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2020-12-31Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry · 2020-11-03Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attentionNeuroImage · 2020-05-22Psychedelics and Psychedelic-Assisted Psychotherapy.Diseño interior · 2020-02-25Emotions and brain function are altered up to one month after a single high dose of psilocybinScientific Reports · 2020-02-09Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low dosesEuropean Neuropsychopharmacology · 2019-11-30Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-07-29Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Cannabis and Cannabinoid Research · 2018-02-28LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in Psychology · 2017-07-24Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and Individual Differences · 2017-06-06Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experienceDrug and Alcohol Dependence · 2017-01-20The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of Psychopharmacology · 2016-11-16Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29Long-term follow-up of psilocybin-facilitated smoking cessation.The American Journal of Drug and Alcohol Abuse · 2016-07-20Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybinDrug and Alcohol Dependence · 2015-10-31The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Psychopharmacology · 2015-07-31Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15Homological scaffolds of brain functional networks.Journal of The Royal Society Interface · 2014-11-30P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.The American Journal of Drug and Alcohol Abuse · 2013-08-31Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'Pure Amsterdam UMC · 2012-05-31Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09Prediction of psilocybin response in healthy volunteers.PLoS ONE · 2012-02-16Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.Journal of Psychopharmacology · 2010-09-19Psychometric evaluation of the altered states of consciousness rating scale (OAV).PLoS ONE · 2010-08-30Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography.Science & Justice · 2006-03-31Multifocal cerebral demyelination after magic mushroom abuse.Journal of neurology · 2000-02-29The effects of psilocybin and lycergic acid on the extinction of avoidance behavior in rats.The Mouseion at the JAXlibrary (Jackson Laboratory) · 1960-12-31